X-Station 2

Suprema Showcases Contactless Access Control at ISC West 2021

Posted by Jay Bartlett July 26, 2021 8:42 am Categories: Access Control, Corporate News. Tags: biometric terminals, BioStar 2, Face Biometrics, FaceStation F2, facial recognition, ISC West, Suprema, X-Station 2.

Suprema is showcasing its latest access control solutions at ISC West 2021. ISC West 2021 marks the first year Suprema is operating a stand-alone booth at ISC West and Suprema is demonstrating advanced access control features of its BioStar 2 solution, in addition to its X-Station 2 and FaceStation F2 terminals. At Suprema booth, visitors can see how BioStar 2 access control solution can be deployed to strengthen security at enterprise settings.

Suprema’s New X-Station 2 Supports Mobile Access, QR Codes and RFID Cards

Posted by Jay Bartlett May 14, 2021 11:13 am Categories: Integrated Systems, Mobile / In-Vehicle, New Products. Tags: Hanchul Kim, RFID cards, Suprema, X-Station 2.

Suprema announced the new product launch of the X-Station 2, a versatile intelligent terminal with credential options of mobile access, QR and barcodes as well as RFID cards and PIN. X-Station 2 enables flexible access control system design by supporting multiple credential options. The terminal is compatible with most types of existing RFID cards including EM, MIFARE, iCLASS, DESFire and FeliCa, but also lets users go card-less by offering mobile credential options including QR codes and barcodes.

How An Innovative Control Room Can Help Secure The Budding Cannabis Market

It’s no secret that the cannabis industry is growing. Numerous states across the United States, from California to Maine, have legalized recreational cannabis, with 33 total states allowing cannabis for medicinal uses. And it’s not just the United States that’s seeing this trend: Canada’s official legalization of recreational cannabis took effect last October. This growth is leading to incredible opportunities in the industry, with the global market valued at $10.3 billion in 2018 and projected to reach $39.4 billion by 2023. This market opportunity expands far beyond the companies that directly deal with the cannabis plant, with numerous adjacent businesses on track to experience benefits.